NCT03807102View on ClinicalTrials.gov

Trial of Tumor Vaccine Used for Adjuvant Therapy in Post Radical Operation Patients With Lung Cancer

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 16, 2024

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2026

Conditions
Lung Cancer
Interventions
BIOLOGICAL

Tumor Vaccine

NeoAntigen Tumor Vaccine (5 injections for each 3 days and then 1 injection for each 3 months till recurrence or up to 2 years).

Trial Locations (1)

410013

Hunan Provincal Tumor Hospital, Changsha

All Listed Sponsors
collaborator

Shanghai Houchao Biotechnology Co., Ltd

UNKNOWN

lead

Yongchang Zhang

OTHER